A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial

Mona Bafadhel, Neil Barnes, Stephen C. Bourke, Chris Compton, Gerard J. Criner, Mark T. Dransfield, David M.G. Halpin, MeiLan K. Han, Benjamin Hartley, C. Elaine Jones, Peter Lange, Sally Lettis, David A. Lipson, David A. Lomas, Neil Martin, Fernando J. Martinez, Robert Wise, Dave Singh

Source: Eur Respir J, 58 (3) 2004522; 10.1183/13993003.04522-2020
Journal Issue: September
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mona Bafadhel, Neil Barnes, Stephen C. Bourke, Chris Compton, Gerard J. Criner, Mark T. Dransfield, David M.G. Halpin, MeiLan K. Han, Benjamin Hartley, C. Elaine Jones, Peter Lange, Sally Lettis, David A. Lipson, David A. Lomas, Neil Martin, Fernando J. Martinez, Robert Wise, Dave Singh. A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial. Eur Respir J, 58 (3) 2004522; 10.1183/13993003.04522-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: